|
|
|
|
|
|
|
1 Chiral Drugs from a Historical Point of View (Joseph Gal). |
|
|
|
|
|
|
|
1.3 Old Chiral Drugs: Natural Remedies 3000BC–1900. |
|
|
|
1.4 Recognition of Chirality in Drugs. |
|
|
|
1.5 Enantioselectivity in Drug Action and Drug Metabolism: The Beginnings. |
|
|
|
1.6 Drug Chirality in the 20th Century. |
|
|
|
|
|
|
|
2 Stereoselective Synthesis of Drugs – An Industrial Perspective (Hans-Jürgen Federsel). |
|
|
|
2.1 Introduction: Historical Overview. |
|
|
|
2.2 Asymmetry from an Industrial Scale Perspective. |
|
|
|
2.3 Stereoselective Processes in Drug Manufacture – Drivers and Blockers. |
|
|
|
2.4 The Metal – Friend and Foe. |
|
|
|
2.5 Ligand Development – At the Core of Catalytic Chemistry. |
|
|
|
2.6 Asymmetric Reactions – A Rich Reservoir. |
|
|
|
2.7 Retrospect and Prospect. |
|
|
|
|
|
3 Aspects of Chirality in Natural Products Drug Discovery (Philipp Krastel, Frank Petersen, Silvio Roggo, Esther Schmitt, and Ansgar Schuffenhauer). |
|
|
|
|
|
3.2 Stereochemical Aspects of Natural Products. |
|
|
|
3.3 Mechanisms of Stereochemical Control in Natural Product Biosynthesis. |
|
|
|
3.4 Biological Activity of Natural Products Related to Stereochemistry. |
|
|
|
|
|
4 Biotransformation Methods for Preparing Chiral Drugs and Drug Intermediates (Michael Müller and Marcel Wubbolts). |
|
|
|
|
|
4.2 Examples of Established Applications of Biocatalysts in the Synthesis of Pharmaceuticals. |
|
|
|
4.3 Some Special Aspects of Biocatalysts, Recent Developments. |
|
|
|
4.4 Conclusions and Outlook. |
|
|
|
|
|
|
|
5 Resolution of Chiral Drugs and Drug Intermediates by Crystallisation (Kazuhiko Saigo). |
|
|
|
|
|
5.2 Physical Enantioseparation – Preferential Crystallization. |
|
|
|
5.3 Chemical Enantioseparation – Diastereomeric Salt Formation. |
|
|
|
5.4 The Bridge Between Preferential Crystallization and Diastereomeric Salt Formation. |
|
|
|
5.5 Process Research on the Enantioseparation of Racemates by Diastereomeric Salt Formation. |
|
|
|
5.6 Examples of Enantioseparations in the Pharmaceutical Industry. |
|
|
|
|
|
6 Isolation and Production of Optically Pure Drugs by Enantioselective Chromatography (Eric Francotte). |
|
|
|
|
|
6.2 General Considerations Regarding the Preparation of Single Stereoisomers of Chiral Drugs. |
|
|
|
6.3 Preparative Chiral Stationary Phases. |
|
|
|
6.4 Strategies for Performing Enantioselective Separations. |
|
|
|
6.5 Preparative Enantioselective Resolution of Chiral Drugs. |
|
|
|
|
|
|
|
7 Stereoselective Chromatographic Methods for Drug Analysis (Norbert M. Maier and Wolfgang Lindner). |
|
|
|
|
|
7.2 The Role of Enantioselective Analysis in Drug Development. |
|
|
|
7.3 Separation Techniques in Enantiomer Analysis. |
|
|
|
7.4 Principle of Enantiomer Separation. |
|
|
|
7.5 Molecular Requirements for Chiral Recognition. |
|
|
|
7.6 Thermodynamic Principles of Enantiomer Separation. |
|
|
|
7.7 Role of Mobile Phase in Enantiomer Separation. |
|
|
|
7.8 Chiral Selectors and Chiral Stationary Phases Employed in Liquid Chromatographic Enantiomer Separation. |
|
|
|
|
|
|
|
8 Capillary Electrophoresis Coupled to Mass Spectrometry for Chiral Drugs Analysis (Serge Rudaz and Jean-Luc Veuthey). |
|
|
|
|
|
8.2 Capillary Electrophoresis (CE). |
|
|
|
|
|
8.4 Chiral Separation Strategies. |
|
|
|
|
|
8.6 Partial Filling – Counter Current Technique. |
|
|
|
8.7 Chiral Micellar Electrokinetic Chromatography. |
|
|
|
8.8 Quantitative Aspects in CE-MS and Parameters for CE-ESI-MS Coupling. |
|
|
|
8.9 Capillary Electrochromatography Coupled to Mass Spectrometry. |
|
|
|
8.10 Discussion and Conclusion. |
|
|
|
|
|
9 Powerful Chiral Molecular Tools for Preparation of Enantiopure Alcohols and Simultaneous Determination of Their Absolute Configurations by X-Ray Crystallography and/or 1H NMR Anisotropy Methods (Nobuyuki Harada). |
|
|
|
|
|
9.2 Methodologies for Determining Absolute Configuration. |
|
|
|
9.3 CSDP Acid, Camphorsultam Dichlorophthalic Acid (–)-1, Useful for the Enantioresolution of Alcohols by HPLC and Simultaneous Determination of Their Absolute Configurations by X-ray Crystallography 287 |
|
|
|
9.4 A Novel Chiral Molecular Tool, 2-Methoxy-2-(1-naphthyl)propionic Acid (MαNP Acid (S)-(+)-3), Useful for Enantioresolution of Alcohols and Simultaneous Determination of Their Absolute Configurations by the <sup>1</sup>H NMR Aisotropy Method. |
|
|
|
9.5 Absolute Configuration of the Thyroid Hormone Analog KAT-2003 as Determined by the 1H NMR Anisotropy Method with MαNP Acid. |
|
|
|
|
|
|
|
10 Keywords in Chirality Modeling Molecular Modeling of Chirality – Software and Literature Research on Chirality in Modeling, Chirality in Docking, Chiral Ligand–Receptor Interaction and Symmetry (Gerd Folkers, Mine Yarim, and Pavel Pospisil). |
|
|
|
|
|
|
|
10.3 Molecular Modeling in Chiral Chromatography. |
|
|
|
10.4 Chirality of Protein Residues, Homology Modeling. |
|
|
|
10.5 Chiral Selective Binding, MDS methods. |
|
|
|
10.6 Docking of Chiral Compounds. |
|
|
|
10.7 Molecular Modeling Software Dealing with Chirality and Some References to Its Successful Application. |
|
|
|
|
|
|